The drop was as high as 99.1%!

 On September 16, the Sichuan Provincial Pharmaceutical Equipment Centralized Procurement and Pharmaceutical Price Supervision Platform issued a public announcement on companies applying for price reductions
.
After sorting out the publicity documents, 64 pharmaceutical companies involved 110 drugs voluntarily applying for price reductions, with a maximum reduction of 99.
1%! The content of the announcement shows: "According to the drug price reduction application submitted by the enterprise on the Sichuan Pharmaceutical Equipment Centralized Purchase and Pharmaceutical Price Monitoring Platform, it is proposed to reduce the linkage reference price of some drugs, and the price reduction will now be announced
.
The publicity period is September 16, 2021 Until September 18, 2021.

" According to the review of the publicity documents, 64 pharmaceutical companies voluntarily applied for price reductions this time, involving 110 drugs, including bevacizumab injection, human interferon α1b for injection, and recombinant human Erythropoietin injection (CHO cells), Aesculus esculentus dispersible tablets, Gastrodin injection, Asarone injection, Cinacalcet hydrochloride tablets, Dexmedetomidine hydrochloride injection, Levofloxacin tablets, Chuangzhi capsules, compound DDB sheet, compound liquorice tablets and the like
.
Among them, the price reduction of compound licorice tablets produced by Inner Mongolia Lantai Pharmaceutical Co.
, Ltd.
is as high as 99.
1%.
According to the formula document, the linkage reference price of Lantai Pharmaceutical Compound Licorice Tablets is 1,200 yuan, and the linkage reference price is 10.
07 yuan after the price reduction is applied
.
In addition to compound licorice tablets, Lantai Pharmaceuticals also applied for price reduction of compound bifendate tablets, which also reduced the price by 97.
2%
.
It is understood that Lantai Pharmaceutical is a comprehensive enterprise integrating the production and sales of salt, salt chemicals, and medical and health products.
The representative products in the medical and health field mainly include Cistanche Yishen Granules, Compound Licorice Tablets, and Weifeng salt algae
.
In addition, the higher price range as well as corporate benevolence Yikang Group Co.
, Ltd.
, Anhui Le Ran Tong Pharmaceutical Co.
, Ltd.
, Harbin Medical University Pharmaceutical Co.
, Ltd.
, the drug Kant music (Shanghai) Pharmaceutical Co.
, Ltd.
and so on
.
For example, the linkage reference price of Anhui Lerantang Pharmaceutical Co.
, Ltd.
Aralia Capsules (each 0.
35g) is 2448 yuan, and the linkage reference price is 68 yuan after the price reduction is applied, and the price reduction rate is 97.
2%
.
The linkage reference price of Daming Capsules (0.
3g per capsule) of Harbin Medical University Pharmaceutical Co.
, Ltd.
is 1,271.
76 yuan.
After applying for a price reduction, the linkage reference price is 52.
99 yuan, and the price reduction rate is 95.
83%
.
The linkage reference price of Cinacalcet Hydrochloride Tablets (25mg (calculated as C22H22F3N)) of Renheyikang Group Co.
, Ltd.
is 198 yuan, and the linkage reference price after applying for a price reduction is 29.
68 yuan, a decrease of 85%
.
The linkage reference price of rotigotine patch (9mg/20cm2 (drug release 4mg/24h)) of Shanghai Pharmaceutical Kangdele (Shanghai) Pharmaceutical Co.
, Ltd.
is 1,144.
29 yuan.
After applying for a price reduction, the linkage reference price is 612 yuan, and the price reduction rate is 46.
52%
.
According to the publicity documents, the multiple batches of cefoxitin sodium for injection, cefuroxime sodium for injection, and ceftazidime for injection produced by Guangdong Jincheng Jinsu Pharmaceutical Co.
, Ltd.
all have a certain degree of price reduction.
This is an enterprise that has applied for a variety of price reductions.

.
For example, ceftazidime for injection (2.
0g), the linkage reference price is 62.
71, and the linkage reference price is 59.
3
.
It is reported that Guangdong Jincheng Jinsu Pharmaceutical Co.
, Ltd.
is a holding company of Shandong Jincheng Pharmaceutical Group Co.
, Ltd.
and an innovative development enterprise in the field of cephalosporins in China
.
It settled in the National Health Base in 2017 .
The company implements the integration of raw materials and preparations and an international development strategy, and has established a high-quality antibiotic preparation industrialization strategy with multinational companies such as ACS DOBFAR GROUP (large cephalosporin company in Europe and the United States), Antibióticos do Brasil Ltd (formerly Eli Lilly in Brazil), and Nectar Lifesciences Ltd.
Cooperation, the main products are: Cefazolin Sodium for Injection (Ansif ANCEF), Cefuroxime Sodium for Injection (KEFUROX), Cefoxitin Sodium for Injection (MEFOXIN), Ceftril for Injection sodium pine (Shi Fu Ze), cefotaxime sodium injection (Kaifu Jie), ceftazidime for injection (complex das FORTAZ) and the like
.